Incannex Healthcare Inc. cotiza a 2.90 USD y tiene una capitalización bursátil de $36M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Incannex Healthcare Inc., a clinical-stage biopharmaceutical company, engages in the research and development of psychedelic medicines and therapies for patients with chronic diseases in Australia. The company develops IHL-42X, an oral fixed dose combination of dronabinol and acetazolamide that is in Phase 2/3 clinical…
| Periodo | 2026-09 | 2026-05 | 2026-02 | 2025-11 |
|---|---|---|---|---|
| Real | $-0.17 | $-0.49 | $-0.85 | $-0.92 |
| Estimado | $-0.57 | $-0.84 | $-0.93 | $-18.09 |
| Sorpresa | +70.2% | +41.7% | +8.6% | +94.9% |
| Métrica | IXHL | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -28.6% | -40.4% | +11.8% |
| ROA | -26.4% | -32.0% | +5.6% |
| Current Ratio | 48.81 | 2.84 | +45.97 |
| Debt / Equity | — | 0.28 | — |